Responses
Hepatology
Original research
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Compose a Response to This Article
Other responses
No responses have been published for this article.